On November 21, 2017 Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, reported that it will present at the LD Micro 10th Annual Main Event in Los Angeles, CA on December 5-7, 2017 (Press release, Navidea Biopharmaceuticals, NOV 21, 2017, View Source [SID1234522199]). Jed Latkin, Chief Financial Officer and Chief Operating Officer of Navidea, will be giving a presentation and meeting with investors throughout the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event:
LD Micro 10th Annual Main Event
Date:
Thursday, December 7th, 2017
Time:
9:30am PT (Pacific Time)
Location:
Luxe Sunset Boulevard Hotel, Los Angeles, CA

For investors attending the LD Micro Conference, please contact Navidea Investor Relations to schedule a meeting with Navidea management at [email protected] or [email protected].

The presentation will be webcast live and remain available for 90 days following the presentation. To access the webcast, please visit the Events tab of the Investor Relations section of the Navidea website at www.navidea.com.